Mutant p53 on the Path to Metastasis

Qiaosi Tang1, Zhenyi Su2, Wei Gu2

  • 1Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.

Trends in Cancer
|January 19, 2020
PubMed

Insights

Mutant p53, a common cancer gene mutation, actively promotes cancer cell spread and metastasis. Understanding these mechanisms is key to developing new therapies for patients with TP53 mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis is the primary cause of cancer mortality.
  • The tumor suppressor gene TP53 is frequently mutated in human cancers.
  • TP53 mutations can result in loss-of-function, dominant-negative, or gain-of-function effects.

Purpose of the Study:

  • To summarize the mechanisms and functions of mutant p53 in promoting cancer metastasis.
  • To discuss the prognostic implications of mutant p53.
  • To review current therapeutic strategies targeting mutant p53.

Main Methods:

  • Literature review and synthesis of existing research on mutant p53 and metastasis.
  • Analysis of studies detailing gain-of-function mechanisms of mutant p53.
  • Examination of data on the prognostic value and therapeutic targeting of mutant p53.

Main Results:

  • Gain-of-function mutant p53 actively enhances cancer cell motility, invasion, and metastasis.
  • Mutant p53 plays a significant role in fostering metastasis across various cancer types.
  • Evidence highlights the prognostic significance of TP53 mutations.

Conclusions:

  • Mutant p53 is a critical driver of cancer metastasis through specific gain-of-function mechanisms.
  • Targeting mutant p53 holds therapeutic potential for improving patient outcomes.
  • Further research is needed to uncover novel mechanisms and develop innovative treatments.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K